BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20693985)

  • 1. Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome.
    Adam P; Hahner S; Hartmann M; Heinrich B; Quinkler M; Willenberg HS; Saeger W; Sbiera S; Schmull S; Voelker HU; Ströbel P; Allolio B; Fassnacht M
    Mod Pathol; 2010 Dec; 23(12):1596-604. PubMed ID: 20693985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal cortical neoplasms: a study of clinicopathological features related to epidermal growth factor receptor gene status.
    Zhang J; Wang C; Gao J; Sun J; Zeng X; Wu S; Liang Z
    Diagn Pathol; 2014 Jan; 9():19. PubMed ID: 24457059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
    Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
    Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
    Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
    Giordano TJ
    Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nestin as a marker in the classification of adrenocortical tumors.
    Lachenmayer A; Lichtenauer UD; Cox T; Schott M; Malendowicz LK; Goretzki PE; Cupisti K; Scherbaum WA; Bornstein SR; Willenberg HS
    Horm Metab Res; 2009 May; 41(5):397-401. PubMed ID: 19294612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling in adrenocortical neoplasia.
    Assie G; Giordano TJ; Bertherat J
    Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologic features and expression of insulin-like growth factor-2 in adrenocortical neoplasms.
    Erickson LA; Jin L; Sebo TJ; Lohse C; Pankratz VS; Kendrick ML; van Heerden JA; Thompson GB; Grant CS; Lloyd RV
    Endocr Pathol; 2001; 12(4):429-35. PubMed ID: 11949624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
    Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the expression of histamine-related genes and proteins in normal human adrenal cortex and adrenocortical tumors.
    Szabó PM; Wiener Z; Tömböl Z; Kovács A; Pócza P; Horányi J; Kulka J; Riesz P; Tóth M; Patócs A; Gaillard RC; Falus A; Rácz K; Igaz P
    Virchows Arch; 2009 Aug; 455(2):133-42. PubMed ID: 19568768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.
    Ye J; Qi Y; Wang W; Sun F; Wei Q; Su T; Zhou W; Jiang Y; Yuan W; Cai J; Cui B; Ning G
    Endocrine; 2012 Jun; 41(3):479-86. PubMed ID: 22311173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
    Åkerström T; Willenberg HS; Cupisti K; Ip J; Backman S; Moser A; Maharjan R; Robinson B; Iwen KA; Dralle H; D Volpe C; Bäckdahl M; Botling J; Stålberg P; Westin G; Walz MK; Lehnert H; Sidhu S; Zedenius J; Björklund P; Hellman P
    Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of aromatase and estrogen receptors in human adrenocortical tumors.
    Barzon L; Masi G; Pacenti M; Trevisan M; Fallo F; Remo A; Martignoni G; Montanaro D; Pezzi V; Palù G
    Virchows Arch; 2008 Feb; 452(2):181-91. PubMed ID: 18157729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of potential surrogate markers of target-specific therapy in archival materials of adrenocortical carcinoma.
    Nakamura M; Miki Y; Akahira J; Morimoto R; Satoh F; Ishidoya S; Arai Y; Suzuki T; Hayashi Y; Sasano H
    Endocr Pathol; 2009; 20(1):17-23. PubMed ID: 19184558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PURE ANDROGEN-PRODUCING ADRENAL TUMOR: CLINICAL FEATURES AND PATHOGENESIS.
    Tong A; Jiang J; Wang F; Li C; Zhang Y; Wu X
    Endocr Pract; 2017 Apr; 23(4):399-407. PubMed ID: 28095038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53 in adrenocortical tumours: clinicopathological correlations.
    McNicol AM; Nolan CE; Struthers AJ; Farquharson MA; Hermans J; Haak HR
    J Pathol; 1997 Feb; 181(2):146-52. PubMed ID: 9120717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of STAT3 and IGF2 in adrenocortical carcinoma and its relationship with angiogenesis.
    Zhu Y; Xu Y; Chen D; Zhang C; Rui W; Zhao J; Zhu Q; Wu Y; Shen Z; Wang W; Ning G; Wang X
    Clin Transl Oncol; 2014 Jul; 16(7):644-9. PubMed ID: 24178245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.